Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Keating

Showing results (841-850 of 1,115) with videos related to

Pageof 112
Sort By:
Blood|October 24, 2015
Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemiaPhilip A Thompson, Constantine S Tam, Susan M O'Brien, et al.
Cancer Research|March 15, 1987
Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patientsS A Maxwell, R Kurzrock, S J Parsons, et al.
Blood Cancer Journal|March 14, 2021
The multi-kinase inhibitor TG02 induces apoptosis and blocks B-cell receptor signaling in chronic lymphocytic leukemia through dual mechanisms of actionRong Chen, Jennifer Tsai, Philip A Thompson, et al.
Cancer|September 1, 2010
Self-administered, subcutaneous alemtuzumab to treat residual disease in patients with chronic lymphocytic leukemiaWilliam G Wierda, Thomas J Kipps, Michael J Keating, et al.
British Journal of Haematology|November 30, 2006
The t(14;19)(q32;q13)-positive small B-cell leukaemia: a clinicopathologic and cytogenetic study of seven casesYang O Huh, Lynne V Abruzzo, George Z Rassidakis, et al.
Cell Transplantation|September 28, 2013
Endothelial progenitor cells enhance islet engraftment, influence β-cell function, and modulate islet connexin 36 expressionDaniella Penko, Darling Rojas-Canales, Daisy Mohanasundaram, et al.
International Journal of Cancer|August 18, 2010
The B cell antigen receptor in atypical chronic lymphocytic leukemia with t(14;19)(q32;q13) demonstrates remarkable stereotypyCarmen D Schweighofer, Yang O Huh, Rajyalakshmi Luthra, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|August 1, 1996
Immunogenetic factors in HPV-associated cervical cancer: influence on disease progressionM F Duggan-Keen, P J Keating, F R Stevens, et al.
Blood|April 8, 2014
Eradication of bone marrow minimal residual disease may prompt early treatment discontinuation in CLLPaolo Strati, Michael J Keating, Susan M O'Brien, et al.
Chemosensory Perception|June 30, 2012
Intensity of Salt Taste and Prevalence of Hypertension Are Not Related in the Beaver Dam Offspring StudyMary E Fischer, Karen J Cruickshanks, Alex Pinto, et al.
Pageof 112

Showing results (841-850 of 1,115) with videos related to

Sort By:
Pageof 112
Blood|October 24, 2015
Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemiaPhilip A Thompson, Constantine S Tam, Susan M O'Brien, et al.
Cancer Research|March 15, 1987
Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patientsS A Maxwell, R Kurzrock, S J Parsons, et al.
Blood Cancer Journal|March 14, 2021
The multi-kinase inhibitor TG02 induces apoptosis and blocks B-cell receptor signaling in chronic lymphocytic leukemia through dual mechanisms of actionRong Chen, Jennifer Tsai, Philip A Thompson, et al.
Cancer|September 1, 2010
Self-administered, subcutaneous alemtuzumab to treat residual disease in patients with chronic lymphocytic leukemiaWilliam G Wierda, Thomas J Kipps, Michael J Keating, et al.
British Journal of Haematology|November 30, 2006
The t(14;19)(q32;q13)-positive small B-cell leukaemia: a clinicopathologic and cytogenetic study of seven casesYang O Huh, Lynne V Abruzzo, George Z Rassidakis, et al.
Cell Transplantation|September 28, 2013
Endothelial progenitor cells enhance islet engraftment, influence β-cell function, and modulate islet connexin 36 expressionDaniella Penko, Darling Rojas-Canales, Daisy Mohanasundaram, et al.
International Journal of Cancer|August 18, 2010
The B cell antigen receptor in atypical chronic lymphocytic leukemia with t(14;19)(q32;q13) demonstrates remarkable stereotypyCarmen D Schweighofer, Yang O Huh, Rajyalakshmi Luthra, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|August 1, 1996
Immunogenetic factors in HPV-associated cervical cancer: influence on disease progressionM F Duggan-Keen, P J Keating, F R Stevens, et al.
Blood|April 8, 2014
Eradication of bone marrow minimal residual disease may prompt early treatment discontinuation in CLLPaolo Strati, Michael J Keating, Susan M O'Brien, et al.
Chemosensory Perception|June 30, 2012
Intensity of Salt Taste and Prevalence of Hypertension Are Not Related in the Beaver Dam Offspring StudyMary E Fischer, Karen J Cruickshanks, Alex Pinto, et al.
Pageof 112